Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment
Public ClinicalTrials.gov record NCT04788264. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Study to Assess Feasibility of a Clinically Significant Increase in Physical Activity in Patients With Head and Neck Cancer Undergoing Active Treatment
Study identification
- NCT ID
- NCT04788264
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Thomas Jefferson University
- Other
- Enrollment
- 12 participants
Conditions and interventions
Conditions
- Head and Neck Carcinoma
- Hypopharyngeal Carcinoma
- Laryngeal Carcinoma
- Lung Carcinoma
- Maxillary Sinus Carcinoma
- Oral Cavity Carcinoma
- Oropharyngeal Carcinoma
- Paranasal Sinus Carcinoma
- Sinonasal Carcinoma
- Stage I Laryngeal Cancer AJCC v8
- Stage II Laryngeal Cancer AJCC v8
- Stage III Laryngeal Cancer AJCC v8
- Stage IV Laryngeal Cancer AJCC v8
- Stage IVA Laryngeal Cancer AJCC v8
- Stage IVB Laryngeal Cancer AJCC v8
- Stage IVC Laryngeal Cancer AJCC v8
Interventions
- Behavioral Intervention Behavioral
- Consultation Other
- Exercise Intervention Other
- Medical Device Usage and Evaluation Other
- Quality of Life Assessment Other
- Questionnaire Administration Other
Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2021
- Primary completion
- Jun 28, 2023
- Completion
- Jun 28, 2023
- Last update posted
- May 21, 2025
2021 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04788264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04788264 live on ClinicalTrials.gov.